EQS-Ad-hoc: STRABAG SE / Key word(s): Acquisition After expiration of deadline: further negotiations of transaction to acquire parts of VAMED Group
The purchase agreement for the acquisition of parts of VAMED Group, concluded in May 2024 between a joint holding company of STRABAG SE and PORR AG as the buyer on the one hand and VAMED AG (a group company of Fresenius SE & Co. KGaA of Germany) as the seller on the other, has not been fulfilled by the contractually agreed date. Among other things, approval from the relevant competition authority has not yet been obtained. The purchase agreement includes VAMED-KMB Krankenhausmanagement und Betriebsführungsges.m.b.H. (VKMB) and VAMED Standortentwicklung und Engineering GmbH (VSG) with the technical operations management and construction projects divisions of Vienna General Hospital (AKH Wien), the Austrian project development business and the spa holdings in Austria. The STRABAG-PORR consortium has therefore entered into further negotiations with the seller regarding the purchase agreement. End of Inside Information
11-March-2025 CET/CEST News transmitted by EQS Group. www.eqs.com |
Language: | English |
Company: | STRABAG SE |
Donau-City-Straße 9 | |
1220 Vienna | |
Austria | |
Phone: | +43 1 22422 – 1089 |
Fax: | +43 1 22422 - 1177 |
E-mail: | investor.relations@strabag.com |
Internet: | www.strabag.com |
ISIN: | AT000000STR1 |
Listed: | Vienna Stock Exchange (Official Market) |
EQS News ID: | 2098772 |
End of Announcement | EQS News Service |
|
2098772 11-March-2025 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.